Posterior Reversible Leukoencephalopathy Syndrome (PRES)

PRES: Posterior reversible leukoencephalopathy syndrome. 

It usually consists of a constellation of features, including:

  • AMS or encephalopathy** – in ~¾ of patients

  • Seizures** – in ~⅔ of patients

    • Often the presenting symptom

  • Headache – in ~½ of patients; global, gradual, refractory to meds

  • Visual changes - in ⅓ of patients

  • Hypertension - may precede the neurologic syndrome by ~24 hours

    • Most common key contributing fracture is a rapid increase in blood pressure

      • In the context of hypertension, PRES is equivalent to hypertensive encephalopathy 

      • BP can related to pre/eclampsia

    • The BP can be normal in ~20% of patients

  • Nausea / vomiting

The symptoms typically progress rapidly over hours or days.

Risk factors:

  • Hypertension – Pre/eclampsia 

  • Renal disease

  • Immunosuppressive meds, e.g.: tacrolimus and cyclosporine, high dose corticosteroids

  • Low magnesium

  • Transplant patient 

Pathophysiology:

  • Usually affects the posterior circulation of the brain

  • Cerebral endothelial dysfunction

  • Failure of autoregulation – usually the cerebral arterioles constrict with HTN

    • If autoregulation fails, the brain experiences high blood pressures

  • Vasogenic cerebral edema due to decreased integrity of the blood brain barrier 

Dx: 

  • MRI will show cerebral edema on the T2-weighted image in the posterior white matter

    • The edema is typically bilateral 

  • PRES is a diagnosis of exclusion

  • Ddx: 

    • R/o stroke, ICH, malignancy, eclampsia, meningoencephalitis, metabolic encephalopathy

Tx:

  • Remove causative factors like immunosuppressive meds

  • Replete magnesium if hypoMg or pre/eclampsia

  • Antiepileptics – benzos are firstline; keppra second line

  • Antihypertensives

    • Options: nicardipine, clevidipine, labetalol

    • Goal to reduce BP by 20-30% within 1 hour

Prognosis:

  • Proper treatment can reduce long term sequelae. 

  • 10-44% can have persistent neurologic deficits 

  • Overall mortality: 3-6%

  • Recovery takes a several days typically 


References:

 ·